People who received a personalised melanoma skin cancer vaccine on top of a standard treatment were 44 per cent less likely to die over the study period than those who had the standard treatment alone
Researchers have used artificial DNA to target and kill cancer cells in a completely new way. The method was effective in lab tests against human cervical cancer- and breast cancer-derived cells, and against malignant melanoma cells from mice. The team cr
(THE CONVERSATION) A defining characteristic of cancer cells is their immortality. Usually, normal cells are limited in the number of times they can divide before they stop growing. Cancer cells, however, can overcome this limitation to form tumors and by
The new shot - designed by Boston biotech Moderna for people with high-risk melanoma - is in the second of three trials and a verdict on whether it works or not is expected within months.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the presentation of positive data from multiple expansion cohorts of an initial Phase 1 trial for an investigational combination of LAG-3 inhibitor fianlimab and PD-1 inhibitor Libtayo® (cemiplimab) in advanced melanoma. The results
According to a new study by researchers at Emory University in Atlanta, the use of broad-spectrum antibiotics in mice with malignant melanoma, an aggressive form of skin cancer
Testing a person's blood for the presence of circulating melanoma cells may help identify skin cancer, while allowing them to skip invasive biopsies, a study published Wednesday found.
A new study offers a possible answer to the question "Why me?" Confirming epidemiological studies, they found that melanomas and lung, bladder and cervical cancers are largely attributable to exposure to carcinogens such as UV light and tobacco, whereas brain and spinal cord tumors called gliomas